How to Get Trikafta Covered by Aetna CVS Health in New York: Complete Prior Authorization and Appeals Guide

Quick Answer: Trikafta requires prior authorization through Aetna CVS Health in New York. Submit requests via EviCore healthcare at least 2 weeks before treatment. Required: CFTR genotype testing showing F508del or eligible mutations, CF diagnosis (ICD-10: E84.0), and pulmonologist documentation. If denied, you have 180 days for internal appeals and 4 months for New York external review through DFS. Start by calling 1-888-632-3862 or submitting through the Availity provider portal.

Table of Contents

  1. Coverage Requirements at a Glance
  2. Step-by-Step: Prior Authorization Process
  3. Common Denial Reasons and Solutions
  4. Appeals Process for New York Patients
  5. New York External Review Rights
  6. Cost-Saving Options
  7. Frequently Asked Questions

Coverage Requirements at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required for all Trikafta prescriptions Aetna Precertification List Aetna
CFTR Genotype Must show F508del or eligible mutations Lab results from certified facility FDA Label
Age Requirement ≥2 years old in US Patient medical records FDA Approval
Diagnosis Code ICD-10: E84.0 (Cystic Fibrosis) Provider documentation Medical coding
Annual Reauthorization Required 30-60 days before expiration Provider portal notification Counterforce Health Guide
Formulary Status Specialty tier (varies by plan) Member formulary document Plan materials

Step-by-Step: Prior Authorization Process

1. Gather Required Documentation

Who: Patient and healthcare provider
Timeline: 1-2 weeks before submission

Collect these essential documents:

  • CFTR genotype test results showing F508del or eligible mutations
  • Complete cystic fibrosis diagnosis with ICD-10 code E84.0
  • Current pulmonary function tests (FEV1 if age ≥6)
  • Baseline liver function tests
  • Documentation of CF-related complications

2. Submit Prior Authorization Request

Who: Healthcare provider
Timeline: At least 2 weeks before treatment start

For New York providers, submit through:

  • Online: Availity provider portal
  • Phone: 1-888-632-3862 (TTY: 711) for commercial plans
  • Specialty Drug Line: 1-866-814-5506 for Trikafta-specific requests
  • Fax: 1-866-249-6155 for specialty medications
Note: New York and northern New Jersey requests are handled by EviCore healthcare, which requires comprehensive clinical documentation.

3. Clinical Review Process

Timeline: 24-48 hours for most requests

Aetna processes over 95% of eligible prior authorizations within 24 hours. The clinical team reviews:

  • Medical necessity based on FDA-approved indications
  • Appropriate CFTR mutation profile
  • Age and weight requirements
  • Liver function monitoring plan

4. Receive Determination

Timeline: 1-5 business days

You'll receive notification via:

  • Provider portal message
  • Phone call to prescriber
  • Written determination letter

Common Denial Reasons and Solutions

Denial Reason How to Overturn Required Documentation
Missing genotype Submit complete CFTR testing Laboratory report with specific mutations identified
Incomplete clinical info Provide comprehensive CF documentation Pulmonologist letter, PFTs, nutritional status
Age restrictions Verify FDA-approved age ranges Birth certificate, medical records
Non-formulary status Request formulary exception Medical necessity letter citing lack of alternatives
Quantity limits exceeded Justify dosing requirements Weight-based calculations, FDA dosing guidelines

Clinician Corner: Medical Necessity Letter

When drafting a medical necessity letter for Trikafta, include these key elements:

Patient Identification

  • Full name, DOB, member ID
  • ICD-10 code E84.0 for cystic fibrosis
  • CFTR genotype with specific mutations

Clinical Justification

  • Current FEV1 percentage (if applicable)
  • Recent pulmonary exacerbation frequency
  • Nutritional status and BMI percentile
  • CF-related diabetes or other complications

Treatment Rationale

  • Reference to FDA-approved indications
  • Cystic Fibrosis Foundation care guidelines
  • Expected clinical benefits based on clinical trials

Monitoring Plan

  • Liver function tests every 3 months (first year)
  • Ophthalmologic exams for cataracts
  • Regular pulmonary assessments

Appeals Process for New York Patients

Internal Appeal (First Level)

Timeline: 180 days from denial date
Process: Submit through Aetna member portal or call member services

Required materials:

  • Original denial letter
  • Updated medical records
  • Peer-reviewed literature supporting use
  • Provider attestation letter

Peer-to-Peer Review

Timeline: 7-14 days from denial
Contact: 1-866-814-5506 for specialty drug P2P requests

The requesting provider can speak directly with Aetna's medical director to discuss:

  • Clinical rationale for Trikafta
  • Patient-specific factors
  • Alternative treatment failures

Expedited Appeals

Timeline: 72 hours for urgent cases
Criteria: Risk to patient health from delay

Mark requests as "URGENT" when:

  • Rapid respiratory decline
  • Hospitalization risk
  • Current therapy failing

New York External Review Rights

New York offers robust external appeal rights through the Department of Financial Services (DFS). This independent review process has overturned many specialty drug denials.

When to File External Review

  • After receiving final internal denial from Aetna
  • Within 4 months of final adverse determination
  • For denials based on "not medically necessary" or "experimental"

External Review Process

  1. File online through the DFS Portal
  2. Pay $25 fee (waived for financial hardship/Medicaid)
  3. Independent medical expert reviews case
  4. Binding decision on Aetna if approved
Success Story: The DFS external appeals database shows several CF medication approvals where independent reviewers cited FDA approval and clinical guidelines to overturn insurer denials.

Timeline for External Review

  • Standard review: 30 days
  • Expedited review: 72 hours for urgent cases
  • Ultra-expedited: 24 hours for urgent drug denials

Getting Help with Appeals

Community Health Advocates: 888-614-5400
Free assistance with filing appeals and understanding your rights in New York.

Cost-Saving Options

Manufacturer Support Programs

Vertex Patient Services: 1-877-752-5933

  • Copay assistance up to $15,000 annually
  • Patient assistance program for uninsured
  • Free drug program for eligible patients

State and Foundation Programs

  • HealthWell Foundation: CF-specific grants
  • Patient Access Network (PAN): Copay assistance
  • New York State ADAP: For qualifying conditions

Counterforce Health helps patients navigate these complex approval processes by creating targeted, evidence-backed appeals that align with each payer's specific requirements. Their platform analyzes denial patterns and crafts point-by-point rebuttals using the right clinical evidence and procedural requirements.

When to Escalate to State Regulators

Contact the New York Department of Financial Services if:

  • Aetna violates appeal deadlines
  • Denial appears to contradict FDA approval
  • Process violations occur during review

File complaints: DFS Consumer Portal or call 1-800-342-3736

Frequently Asked Questions

How long does Aetna prior authorization take in New York?
Most Trikafta requests are processed within 24-48 hours when complete documentation is submitted. EviCore healthcare handles New York requests and may take up to 5 business days for complex cases.

What if Trikafta is non-formulary on my plan?
Request a formulary exception by demonstrating medical necessity. Include documentation that no formulary alternatives are appropriate for your specific CFTR mutations.

Can I request an expedited appeal?
Yes, if delay could risk your health. Call 1-888-632-3862 and clearly state the urgency. Expedited appeals must be decided within 72 hours.

Does step therapy apply to Trikafta?
This varies by individual Aetna plan. Some require trials of other CFTR modulators first, while others only require genetic documentation. Check your specific plan's pharmacy policy.

What happens during annual reauthorization?
Submit updated clinical documentation 30-60 days before your current approval expires. Include recent PFTs, liver function tests, and continued medical necessity.

How much does Trikafta cost without insurance?
The annual list price exceeds $300,000. However, Vertex offers substantial patient assistance programs that can reduce or eliminate costs for eligible patients.

Can I appeal if I move to New York from another state?
Yes, but you'll need to establish care with a New York CF center and may need updated documentation meeting Aetna's current requirements.

Sources and Further Reading


Disclaimer: This information is for educational purposes only and does not constitute medical advice. Always consult with your healthcare provider and insurance plan for specific coverage decisions. Insurance policies and requirements change frequently—verify current information with your plan before making healthcare decisions.

For personalized help with Trikafta appeals and prior authorization, visit Counterforce Health to learn how their platform can help turn insurance denials into targeted, evidence-backed approvals.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.